From genetic alterations to new molecular targets in pituitary disorders
3.9 Impact Factor
Guardado en:
| Autores principales: | Ferraris, Jimena, Perez Millan, María Inés, Petiti, Juan Pablo |
|---|---|
| Otros Autores: | https://orcid.org/0000-0001-7472-0439 |
| Formato: | publishedVersion article |
| Lenguaje: | Inglés |
| Publicado: |
2024
|
| Materias: | |
| Acceso en línea: | http://hdl.handle.net/11086/552688 https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2024.1375475/full https://doi.org/10.3389/fendo.2024.1375475 |
| Aporte de: |
Ejemplares similares
-
Exposure to the plasticizer DEHP during development and lactation alters the pituitary-testicular axis
por: Perez, PA, et al.
Publicado: (2022) -
Oxidative stress and mitochondrial adaptive shift during pituitary tumoral growth
por: Sabatino, María Eugenia, et al.
Publicado: (2023) -
FGF2/FGFR1 pathway inhibition modulates the proliferation of secreting pituitary tumor cells
por: Turina, A, et al.
Publicado: (2022) -
Regulation of pituitary tumors proliferation induced for the FGF2/FGFR1 pathway
por: Villafañe , FM, et al.
Publicado: (2021) -
Baculovirus-based gene silencing of Humanin for the treatment of pituitary tumors
por: Gottardo, María Florencia, et al.
Publicado: (2018)